Dr. Richard C. Lock, MD

Dr. Lock practices at Tawakkol Surgical, LLC in Houston, Texas.

Dr. Lock's NPI, 1558334219, was assigned on February 10, 2006. Dr. Lock graduated from McGovern Medical School in 1991. Dr. Lock's Texas license number on file is J7052.

Dr. Lock's primary practice is Tawakkol Surgical, LLC, at 12121 Richmond Ave, Houston, TX 77082 in Harris County. The practice phone is (281) 293-8307.

Dr. Lock's primary practice is Tawakkol Surgical, LLC in Houston, Texas. Dr. Lock is also affiliated with Memorial Hermann Greater Heights Hospital. Dmand AI also links Dr. Lock to 4 more hospitals, 3 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lock practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lock's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lock is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lock's licenses on file in 2 states: Texas and California.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, aneurysm, arthritis, asthma and bronchitis among the conditions Dr. Lock treats.

CMS data shows 1,337 Medicare services from Dr. Lock across 9 procedure codes in 2024, for 341 Medicare patients. Medicare paid $101,504 for them. Every service was in an office.

CMS counts 341 Medicare patients who saw Dr. Lock in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lock's median patient age at 67, with 48% women.

In 2024, Dr. Lock wrote 23,335 Medicare Part D claims for 1,347 patients. 89% of them were for generic drugs. CMS names the drug for 22,456 of them, across 209 drugs with 11 or more claims each, at $1,597,598 in total drug cost. In 2023, CMS named 21,625 claims across 205 drugs.

Dr. Lock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lock as offering telehealth.

Dmand AI links 26 papers to Dr. Lock, published from 2011 to 2023. 2011 was the busiest year, with 5. The most frequent topics are Xenograft Model Antitumor Assays, Cell Line, Tumor and Mice, SCID. Dr. Lock has published most often in Pediatr Blood Cancer. Dr. Lock's most frequent co-authors are Richard G. Gorlick, MD, John M. Maris, MD and E Anders Kolb, MD.

CMS Open Payments shows 1,292 general payments to Dr. Lock from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,833.

Dr. Lock graduated from McGovern Medical School in 1991.

Dr. Lock is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.